Key Takeaways The broader U.S. equity markets witnessed intense volatility over the past few days, triggered by concerns regarding AI disruption across the spectrum, geopolitical unrest and the annulment of President Trump's signature tariffs. As simmering tensions between the United States and Iran kept the markets on edge, the downtrend was amplified by increasing skepticism about how AI will impact the broader economy after hitting various sectors outside the purview of the technology industry. Sticky in ...

Key Takeaways Morgan Stanley (MS) and Evercore Inc. (EVR) represent two distinct, top-tier investment banking (IB) models. Morgan Stanley pairs advisory and capital markets strength with sizable wealth and asset management platforms that diversify earnings. Evercore is a leading independent advisory boutique, built around high- margin M&A and restructuring advice with a leaner balance sheet profile. Both have shown resilience as M&A and IPO activity recovered in 2024-2025. With the IB outlook turning bright ...

The expanded MTC will enable consolidation of piloting, application development and advanced engineering prototyping under one roof. In addition to unifying talent, tools and technology, the expansion also includes the relocation of the Santoprene TPV piloting operation from Houston to Michigan, creating a centralized hub for extrusion development, foaming technologies and advanced engineering while reducing overall costs. This customer-centered innovation engine enables hands-on co-development with experts ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done. A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. ECO is quite a good fit in this regard, gaining 36.9% over this period. However, it's not enough to look at the price change f ...

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potential fails to justify their swelled-up valuation. In that phas ...

Key Takeaways Henry Schein, Inc. (HSIC) registered fourth-quarter 2025 adjusted earnings per share (EPS) of $1.34, up 12.6% from the year-ago period's figure. The bottom line also surpassed the Zacks Consensus Estimate by 3.1%. Excluding adjustments, such as restructuring costs, acquisition intangible amortization and others, the company reported a GAAP EPS of 85 cents compared with the year-ago quarter's 74 cents. Global Distribution and Value-Added Services Sales in the segment rose 7% year over year on a ...

Key Takeaways Rocket is simultaneously integrating Redfin and Mr. Cooper, which adds execution risk and keeps costs and interest elevated. Even so, management is targeting meaningful synergies across both deals, and AI-enabled capacity is central to how those benefits are expected to drop through to profitability. Rocket is applying AI-enabled automation to remove friction from the labor-intensive parts of mortgage production. The company is using automation to streamline document intake, income and asset v ...

Key Takeaways EverQuote, Inc. (EVER) reported fourth-quarter 2025 operating net income per share of $1.54, significantly exceeding the Zacks Consensus Estimate by 340%. The bottom line increased 366.7% from the prior-year period's level. EverQuote, Inc. Price, Consensus and EPS Surprise EverQuote, Inc. price-consensus-eps-surprise-chart | EverQuote, Inc. Quote EVER's Q4 Results in Detail Revenues in the Automotive insurance vertical grew 32.3% year over year to $179.9 million, surpassing the Zacks Consensus ...

Over the last four quarters, the company has not been able to surpass consensus EPS estimates. AdaptHealth, which belongs to the Zacks Medical - Products industry, posted revenues of $846.29 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.99%. This compares to year- ago revenues of $856.65 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recent ...

Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $1.13. This compares to a loss of $1.09 per share a year ago. These figures are adjusted for non-recurring items. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$1.14 on $15.49 million in revenues for the coming quarter and -$4.63 on $55.85 million in revenues for the c ...